Concepedia

Pamela Pemberton

PP

Statistics

Publications

5

Citations

321

H-Index

5

Active since

2000

Affiliations

Wayne State University(Current)

The Barbara Ann Karmanos Cancer Institute

Pamela Pemberton is an author at Wayne State University specializing in hematologic oncology, chemotherapy in hematologic malignancies, and hematology.

Publications per year

2000–2006

5

Publications

5

The effect of dose increase of imatinib mesylate in patients with chronic or accelerated phase chronic myelogenous leukemia with inadequate hematologic or cytogenetic response to initial treatment.

Jeffrey A. Zonder, Pamela Pemberton, Helen Brandt et al. · PubMed · 2003 · 103 citations

, , +14

Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia.

Mary Varterasian, Ramzi M. Mohammad, Muhammad Shurafa et al. · PubMed · 2000 · 97 citations

, , +17

The effect of imatinib mesylate on patients with Philadelphia chromosome-positive chronic myeloid leukemia with secondary chromosomal aberrations.

Anwar N. Mohamed, Pamela Pemberton, Jeffrey A. Zonder et al. · PubMed · 2003 · 69 citations

, , +17

Phase II Study of Bryostatin 1 in Patients with Relapsed Multiple Myeloma

Mary Varterasian, Pamela Pemberton, Kim Hulburd et al. · Investigational New Drugs · 2001 · 42 citations

, , +15

A comparative study of two types of urinary sheath.

Pamela Pemberton, Anthony G. Brooks, Christina Mai Eriksen et al. · PubMed · 2006 · 10 citations

, , +7

1–5 of 5